In addition to the contribution of EMMPRIN to the mechanistic details of the disease process, plasma EMMPRIN levels may be informative as a biomarker for stroke patients, so that effective medications for these conditions can be promptly initiated. This evidence concerns the gene BSG and stroke disorder.